维普期刊资源整合服务平台（V6.5）

20篇 您的检索式：作者名="Paridaens H"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

	题名	作者	年代	出处	被引量
1	Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors:final results of phase Ⅱ Swiss Group for Clinical Cancer Research Trial显示文摘	Perey L Paridaens R Hawle H	2007	Ann Oncol2007，18，1：	1
2	PDGF enhances orbital fibroblast responses to TSHR stimulating autoantibodies in Graves'ophthalmopathy patients显示文摘	van Steensel L Hooijkaas H Paridaens D		0，，06：	1
3	Phase I/II pharmaeoki- netic study of pemetrexed and epirubicin in patients with locally advanced or metastatic breast cancer显示文摘	Paridaens R Dirix L Dumez H	2007	Clin Breast Cancer2007，7，11：	1
4	Phase Ⅰ/11 pharmacokinetic study of pemetrexed and epirubicin in patients with locally advanced or metastatic breast cancer显示文摘	Paridaens R Dirix L Dumez H		0，，11：	1
5	Clinical benefit of fulvestrant in postmenopansal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors : final results of phase II Swiss Group for Clinical Cancer Research Trial (SAKK 21/00) 显示文摘	Perey L Paridaens R Hawie H	2007	Ann Oneol2007，18，1：	1
6	Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors:final results of phase Ⅱ Swiss Group for Clinical Cancer Research Trial显示文摘	Perey L Paridaens R Hawle H	2007	Ann Oncol2007，，18：	1
7	Phase Ⅰ / Ⅱ pharmacokinetic study of pemetrexed and epirubicin in patients with locally advanced or metastatic breast cancer显示文摘	Paridaens R Dirix L Dumez H	2007	Clin Breast Cancer2007，7，11：	1
8	Phase I/II pharmacokinetic study of pemetrexed and epirubicin in patients with locally advanced or metastatic breast cancer 显示文摘	Paridaens R Dirix L Dumez H	2007	Clin Breast Cancer2007，7，11：	1
9	Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors: final results of phase Ⅱ Swiss Group for Clinical Cancer Research Trial (SAKK 21/00) 显示文摘	PEREY L PARIDAENS R HAWLE H	2007	Ann Oncol2007，18，：	1
10	Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors: final results of phase Ⅱ Swiss Group for Clinical Cancer Research Trial显示文摘	Perey L Paridaens R Hawle H	2006	Ann Oncol2006，10，：	1
11	Phase Ⅰ/Ⅱ pharmacokinetic study of pemetrexed and epirubiein in patients with locally advanced or metastatic breast cancer显示文摘	Paridaens R Dirix L Dumez H	2007	Clin Breast Cancer2007，7，11：	1
12	Clinical benefit of fulvcs- trant in postmcnopausal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors: final results of phase Ⅱ Swiss Group for Clinical Cancer Research Trial (SAKK 21/00) 显示文摘	Percy L Paridaens R Hawle H	2007	Ann Oncol2007，18，1：	1
13	Amniotic membrane transplantation in the management of conjunctival malignant melanoma and primary acquired melanosis with atypia显示文摘	Paridaens D Beekhuis H van Den Bosch W	2001	Br J Ophthalmo12001，85，6：	1
14	Syndrome of inappro -priate antidiuretic hormone associated with chemotherapy inducedtumour lysis in small - cell lung cancer: case report and literaturereview显示文摘	Vanhees S L Paridaens H Vansteenkiste J F	2000	Ann Oncol2000，11，8：	1
15	Phase Ⅰ/Ⅱ pharmacokinetic study of pemetrexed and epirubicin in patients with locally advanced or metastatic breast cancer 显示文摘	Paridaens R Dirix L Dumez H	2007	Clin Breast Cancer2007，7，11：	1
16	Phase I/II pharmacokinetic study of pemetrexed and epirubicin in patients with locally advanced or metastatic breast cancer显示文摘	Paridaens R Dirix L Dumez H	2007	Clinical Breast Cancer2007，7，11：	1
17	Phase Ⅰ / Ⅱ pharmacokinet- ic study of pemetrexed and epirubicin in patients with locally ad- vanced or metastatic breast cancer显示文摘	Paridaens R Dirix L Dumez H	2007	Clin Breast Cancer2007，7，11：	1
18	Phase Ⅰ/Ⅱ pharmaco-kinetic study of pemetrexed and epirubicin in patients with locally advanced or metastatic breast cancer显示文摘	Paridaens R Dirix L Dumez H		0，，11：	1
19	Taxanes in elderly breast cancer patients 显示文摘	WILDIERS H PARIDAENS R	2004	Cancer Treat Rev2004，30，4：	1
20	Matrix metalloproteinase expression patterns in luminal A type breast carcinomas显示文摘	Decock J Hendrickx W Drijkoningen M Wildiers H Neven P Smeets A Paridaens R	2007	Dis Markers2007，23，3：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示